Mutational analysis of extranodal marginal zone lymphoma of mucosa associated lymphoid tissue (MALT lymphoma) in the salivary gland of patients with Sjögren*s syndrome: identification of driver mutations and therapeutic targets

Mutational analysis of extranodal marginal zone lymphoma of mucosa associated lymphoid tissue (MALT lymphoma) in the salivary gland of patients with Sjögren*s syndrome: identification of driver mutations and therapeutic targets - Mutational analysis of ENMZL associated with Sjogren syndrome.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43147

Enrollment

Registered

2017-02-14

Start date

2017-02-10

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lymphoid cancer

Interventions

MALT lymphoma

Mutational analysis

Sjogren disease

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Patients previously diagnosed with a MALT lymphoma

Exclusion criteria

Exclusion criteria: n.a.

Design outcomes

Primary

Measure	Time frame
Detection of recurrent mutations in MALT lymphoma associated with Sjogrens disease.	—

Secondary

Measure	Time frame
n.a.	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)